explore -WSS

explore

author：hotspot 2025-10-06 19:50:32 - browse：6396

Cambridge: AbbVie — Ruby Wallau for STAT

AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology.

Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian cancer in 2022.

Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. AbbVie’s acquisition is the latest multibillion-dollar deal in the space, following Merck’s $22 billion agreement with ADC specialist Daiichi Sankyo and Pfizer’s $43 billion buyout of Seagen earlier this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Grail is spending more than ever lobbying Congress

leisure time

WSS

Doctors are clamoring for more clarity on Paxlovid prescribing

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Pfizer's Covid pill remains 89% effective in final analysis, company says

Connecting traumatic brain injury and domestic violence

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

PhRMA sues HHS over Medicare drug price negotiation

entertainment

explore

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

'Brian's Song' at 50 still offers lessons about cancer for today

The cancer drug shortage isn’t new — and neither are the solutions

New case study details death in closely watched Alzhiemer's trial

At least 13 dead in Texas as scorching temps continue

It was time to plan for my old age. If only I could stop crying

Wildfire smoke exposes gaps in outdoor worker protections

Doctors are clamoring for more clarity on Paxlovid prescribing

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Election results set back Medicaid expansion plans

focus

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Flash flood warnings continue for parts of Missouri, Illinois

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

NFL doctors' conflicts of interest could endanger players, report says

Doctors push to include dialysis machines in emergency stockpile

Wikipedia

focus

leisure time

focus